The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is considered to be the most common endocrine disorder in women of reproductive age, yet debate over appropriate diagnostic criteria and design limitations with sampling methodology have left some doubt as to the actual prevalence in the community. The objective of this study was to create a representative prevalence estimate of PCOS in the community under the National Institutes of Health (NIH) criteria and the more recent Rotterdam consensus criteria and Androgen Excess Society (AES) criteria. METHODS: A retrospective birth cohort study was carried out in which 728 women born during 1973-1975 in a single maternity hospital were traced and interviewed in adulthood (age = 27-34 year; n = 728). Symptoms of PCOS (hyperandrogenism, menstrual dysfunction and polycystic ovaries) were identified by examination and the presence of polycystic ovaries in those that did not consent to the ultrasound were imputed. RESULTS: The estimated prevalence of PCOS in this birth cohort using the NIH criteria was 8.7 +/- 2.0% (with no need for imputation). Under the Rotterdam criteria, the prevalence was 11.9 +/- 2.4% which increased to 17.8 +/- 2.8% when imputed data were included. Under the AES recommendations, PCOS prevalence was 10.2 +/- 2.2%, and 12.0 +/- 2.4% with the imputed data. Of the women with PCOS, 68-69% did not have a pre-existing diagnosis. CONCLUSIONS: The Rotterdam and AES prevalence estimates were up to twice that obtained with the NIH criteria in this, as well other prevalence studies. In addition, this study also draws attention to the issue of many women with PCOS in the community remaining undiagnosed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Polycystic ovary syndrome is one of the most common endocrine disorders affecting adolescent females [1–4] and is associated with an increased risk of impaired glucose tolerance (IGT), impaired fasting glucose, and type 2 diabetes mellitus.”
From Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity (2022) · cites this paper as [2]
In the citing paper
“Despite the high prevalence, PCOS is an underrecognized condition, and many women remain undiagnosed (1).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [1]
In the citing paper
“being more common among those who are overweight or of Indigenous background.”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [1]
In the citing paper
“Polycystic ovary syndrome (PCOS) has recently been shown to affect a striking 12%-21% of Australian reproductive-age women”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [1]
In the citing paper
“It is estimated that 70% of Australian women with PCOS remain undiagnosed”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [1]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Under the NIH criteria, PCOS was defined as the combination of menstrual disorders (as indicated previously) together with clinical and/or biochemical hyperandrogenism.”
MethodThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 3×
“This workshop suggested the addition of a third criteria—the presence of polycystic ovaries—as well as a statement that any two of the three criteria were sufficient for a positive diagnosis (The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004).”
InfluentialSelf-citationKnochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Wang, E.-Y., & Li, S.-Y. (1990) · Cited by 884
Li, S.-Y., & Wang, E.-Y. (1990) · Springer eBooks · doi:10.1007/978-3-642-74821-9 · Cited by 882
Asuncion, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2434 · Cited by 791
Zhu, S., Wang, Z., Heshka, S., Heo, M., Faith, M. S., & Heymsfield, S. B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.743 · Cited by 682
Broekmans, F., Knauff, E., Valkenburg, O., Laven, J., Eijkemans, M., & Fauser, B. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01008.x · Cited by 442
Polycystic ovaries and associated clinical and biochemical features in young women
Michelmore, K. F., Balen, A. H., Dunger, D. B., & Vessey, M. P. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00886.x · Cited by 439
Habershon, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)93067-6 · Cited by 367
Crosignani, P. G. (2003) · Human Reproduction · doi:10.1093/humrep/deg367 · Cited by 361
Fetal growth, length of gestation, and polycystic ovaries in adult life
Cresswell, J., Barker, D., Osmond, C., Egger, P., Phillips, D., & Fraser, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06062-5 · Cited by 241
Self-citationDeUgarte, C. M., Woods, K. S., Bartolucci, A. A., & Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2301 · Cited by 223
What is polycystic ovary syndrome?: Are national views important?
Balen, A. (2002) · Human Reproduction · doi:10.1093/humrep/17.9.2219 · Cited by 198
Prevalence of polycystic ovary syndrome in unselected women from southern China
Chen, X., Yang, D., Mo, Y., Li, L., Chen, Y., & Huang, Y. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.12.018 · Cited by 171
Kumarapeli, V., Seneviratne, R. D. A., Wijeyaratne, C. N., Yapa, R. M. S. C., & Dodampahala, S. H. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn137 · Cited by 170
Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
Somunkiran, A., Yavuz, T., Yucel, O., & Ozdemir, I. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.01.012 · Cited by 166
on behalf of the SHARE Investigators, Razak, F., Anand, S., Vuksan, V, Davis, B., Jacobs, R., Teo, K. K., & Yusuf, S. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802937 · Cited by 161
Kauffman, R. P., Baker, T. E., Baker, V. M., DiMarino, P., & Castracane, V. D. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.037 · Cited by 121
Endometrial carcinoma; ovarian dysfunction — a risk factor in young women
Dahlgren, E., Friberg, L.-G., Johansson, S., Lindström, B., Odén, A., Samsioe, G., & Janson, P. O. (1991) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(91)90092-y · Cited by 117
Ferriman Gallwey Self-Scoring I: Performance Assessment in Women with Polycystic Ovary Syndrome
Wild, R. A., Vesely, S., Beebe, L., Whitsett, T., & Owen, W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2243 · Cited by 106
Cardiovascular Disease Risk Factors in Polycystic Ovary Syndrome
Dokras, A. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992923 · Cited by 100
A practical approach to the diagnosis of polycystic ovary syndrome
Chang, R. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.04.045 · Cited by 97
CARDIOVASCULAR CONSEQUENCES OF POLYCYSTIC OVARY SYNDROME
Amowitz, L. L., & Sobel, B. E. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70079-7 · Cited by 77
Yonkers, A. J., Tm, G., Ga, M., Jl, W., & Re, B. (1981) · PubMed · Cited by 73
Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia
LOWE, P., KOVACS, G., & HOWLETT, D. (2005) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2005.00334.x · Cited by 49
Mulders, A. G. M. G. J., ten Kate-Booij, M., Pal, R., Kruif, M. D., Nekrui, L. C., Oostra, B. A., Fauser, B. C. J. M., & Laven, J. S. E. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61687-2 · Cited by 19
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
“8%) in the first community-based prevalence study based on current Rotterdam diagnostic criteria [5].”
InfluentialBozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“PCOS and evolution The prevalence of PCOS is similar in various populations worldwide”
BackgroundCriteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Metadata
- Authors
- March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J.
- Affiliations
- The University of Adelaide (AU)
- University of Southampton (GB)
- Corresponding author
- Davies, M. J.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-12
- Volume
- 25
- Issue
- 2
- Pages
- 544-551
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2108067228
- Cited by
- 1,799
- References
- 37
- Citations by year
- 2026: 55 · 2025: 92 · 2024: 107 · 2023: 118 · 2022: 130 · 2021: 166 · 2020: 154 · 2019: 149 · 2018: 139 · 2017: 126 · 2016: 118 · 2015: 120 · 2014: 108 · 2013: 83 · 2012: 64
- FWCI
- 52.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, prevalence, diagnostic criteria, Rotterdam criteria, NIH criteria, hyperandrogenism, menstrual disorders, polycystic ovary, birth cohort, women of reproductive age
- MeSH terms
- Adult, Female, Humans, Polycystic Ovary Syndrome, Retrospective Studies, South Australia, Cohort Studies, Prevalence, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.